GIDEON THUO: Open Payments
NPI 1518540038 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 9 payments from 6 companies in 2025. Trend: 2023 $15 · 2024 $30 · 2025 $242
Food & beverage: $131Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $135 |
| Vanda Pharmaceuticals Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Alkermes, Inc. | 1 | $14 |
Products named: FANAPT, REXULTI, UZEDY, CAPLYTA, VRAYLAR, ARISTADA.
Industry payments across NJ — which companies pay providers there.
